TLR7 and colitis: The TLR7 agonist Imiquimod alleviates DSS-induced colitis in mice by inducing the expression of type I interferons (IFN) and antimicrobial peptides (AMPs) and inhibits the survival of intracellular pathogens such as Salmonella [31].